You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
人福醫藥(600079.SH):聘任杜文濤爲公司總裁

格隆匯6月10日丨人福醫藥(600079.SH)公佈,公司董事會於2025年6月9日收到公司董事李傑先生、董事兼總裁鄧霞飛先生、副總裁李莉娥女士提交的書面辭職報告。

在公司臨時股東會選舉出新的董事就任前,李傑先生、鄧霞飛先生將繼續履行董事相關職責;鄧霞飛先生自董事會收到辭職報告之日起不再擔任公司總裁職務,李莉娥女士自董事會收到辭職報告之日起不再擔任公司副總裁職務。公司董事會將按照法定程序儘快完成選舉新任董事相關工作,同時李傑先生、鄧霞飛先生、李莉娥女士將按照公司相關規定做好交接工作,並逐步辦理下屬控股子公司職務的離任手續,不會影響公司的正常經營發展。

截至本公告日,李傑先生持有公司股票86,747,204股,鄧霞飛先生持有公司股票1,572,966股,李莉娥女士持有公司股票513,018股,均不存在應當履行而未履行的承諾事項。

爲完善公司治理結構,保證公司日常經營穩定,根據《公司法》《公司章程》等相關規定,經公司董事長提名,公司於2025年6月10日召開第十屆董事會第七十九次會議,會議審議通過了《關於聘任公司總裁的議案》,聘任公司原副總裁杜文濤先生爲公司總裁,任期與本屆董事會相同。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account